Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Churg-Strauss Syndrome with Renal Involvement
NCT00424749Phase 2Terminated
- Start
- Jun 2007
- Primary completion
- Jul 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in eosinophilic granulomatosis with polyangiitis (EGPA). Started Jun 2007; status: terminated.
02
Drugs
rituximab
03
Conditions
eosinophilic granulomatosis with polyangiitis (EGPA)
Beyond the preview
Go deeper on NCT00424749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00424749.